RR Donnelley introduces its new MultiTrans® Translation Management System (TMS), with innovative features and a new user interface
LONDON, 2016-06-06 07:30 CEST (GLOBE NEWSWIRE) --
R. R. Donnelley & Sons Company(Nasdaq:RRD), a world leader in multi-channel communications, announces the release of the MultiTrans 2017 TMS, its next-generation translation management system designed to help organizations localize their content more cost effectively.
MultiTrans 2017 includes innovative features for project management, translation editing, translation memory and terminology management, all delivered in a redesigned workflow. With just one click, users can see their projects, quotes, invoices and reports.
Additionally, MultiTrans 2017 can be integrated with a larger number of 3rdparty systems, allowing users to submit projects via their own content management system. Supported systems include AEM, Stibo, Documentum, SharePoint and WordPress. The Web Editor – now cross-browser and cross-platform – allows users to seamlessly operate within a secure online translating environment.
New deployment and integration options are available to give clients maximum flexibility. For example, Managed MultiTrans TMS provides clients access to a centralized, tailored Customer portal and to the expert linguistic services of RR Donnelley Language Solutions. In a secure, managed environment, clients enjoy full control over their projects and processes, as well as enhanced visibility of all their language services.
“At a time when businesses around the world are entering new markets and engaging in omni-channel discussions with multiple audiences, organizations need technology to help them manage more content in more languages,” explains Tom Juhase, President, Financial Services Group at RR Donnelley. “MultiTrans 2017 TMS delivers meaningful innovations to better serve our clients across the globe.”
“This new wave of innovation from MultiTrans will play a key role in our clients’ translation processes,” adds Christophe Djaouani, Vice President and Managing Director of RR Donnelley Language Solutions. “Thanks to MultiTrans 2017, we are providing them with even more efficiency and ultimately making things easier for all users involved.”
RR Donnelley(Nasdaq:RRD) helps organizations communicate more effectively by working to create, manage, produce, distribute and process content on behalf of our customers. The company assists customers in developing and executing multichannel communication strategies that engage audiences, reduce costs, drive revenues and increase compliance. RR Donnelley's innovative technologies enhance digital and print communications to deliver integrated messages across multiple media to highly targeted audiences at optimal times for clients in virtually every private and public sector. Strategically located operations provide local service and responsiveness while leveraging the economic, geographic and technological advantages of a global organization.
For more information, and forRR Donnelley'sGlobal Social Responsibility Report, visit the company's website atwww.rrdonnelley.com.
About RR Donnelley Language Solutions
RR Donnelley Language Solutions is a leading, recognized and trusted localization brand supporting corporations across industries in over 140 languages. This global business entity of RR Donnelley provides a full range of linguistic products and services (including translation, interpreting, transcreation, multilingual typesetting, software localization, and voiceover) wrapped around its market-leading MultiTrans language technology.
For more information aboutRR Donnelley Language Solutions, visit our website atwww.rrdonnelley.com/languagesolutions.
MultiTrans is a modular translation management system (TMS) that centralizes and automates translation workflows, leverages translation memory, and unifies terminology across an organization and its communications. To remainat thecutting edge of TMS technology, MultiTrans teams across the globe continuallystrive to innovate and develop newsolutions, including the development of new features and connectors, in order to best respond to their clients’ever-evolving translationneeds.
Use of Forward-Looking Statements
This news release may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and theU.S.Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements and any such forward-looking statements are qualified in their entirety by reference to the following cautionary statements. All forward-looking statements speak only as of the date of this news release and are based on current expectations and involve a number of assumptions, risks and uncertainties that could cause the actual results to differ materially from such forward-looking statements. Readers are strongly encouraged to read the full cautionary statements contained inRR Donnelley'sfilings with theSEC.RR Donnelleydisclaims any obligation to update or revise any forward-looking statements.
Dave Gardella, Senior Vice President Finance:
Tel: +1 312-326-8155
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Nasdaq OMX
Oxford Immunotec21.11.2017 15:16 | pressemeddelelse
Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference
Crown Bioscience Inc.21.11.2017 14:02 | pressemeddelelse
CrownBio's Translatable FATZO Model Utilized in Eli Lilly's Preclinical Type 2 Diabetes Research Programs
OmniComm Systems Inc.21.11.2017 14:02 | pressemeddelelse
OmniComm Systems Signs Letter of Intent to Acquire Certain Assets of Algorithm and its Subsidiary Algorics
Nasdaq21.11.2017 11:32 | pressemeddelelse
Port Moresby Stock Exchange (POMSoX) Launches New Nasdaq Trading System
CloudCraze21.11.2017 08:02 | pressemeddelelse
CloudCraze Joins the Pledge 1% Movement, Makes Commitment to Philanthropic Leadership
TESARO, Inc.20.11.2017 13:02 | pressemeddelelse
TESARO Announces European Commission Approval of ZEJULA® for Women With Recurrent Ovarian Cancer
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum